Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-13 Cr₹1.01 Cr₹-15 Cr₹-44 Cr₹130 Cr

What is the latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Financing Activities ratio of WINDLAS BIOTECH is ₹-13 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-13 Cr
Mar2025₹1.01 Cr
Mar2024₹-15 Cr
Mar2023₹-44 Cr
Mar2022₹130 Cr

How is Cash Flow from Financing Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-13 Cr
Negative
Mar2025 ₹1.01 Cr
Positive
Mar2024 ₹-15 Cr
Negative
Mar2023 ₹-44 Cr
Negative
Mar2022 ₹130 Cr -

Compare Cash Flow from Financing Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,730.1 Cr 1.7% 2.6% -4.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,458.0 Cr 0.7% 8.1% 16% Stock Analytics
DIVIS LABORATORIES ₹193,383.0 Cr 7% 10.2% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,829.0 Cr 2.5% 11.3% 49.6% Stock Analytics
CIPLA ₹116,164.0 Cr -0.3% 4.1% -3.3% Stock Analytics
DR REDDYS LABORATORIES ₹102,648.0 Cr -3.2% -3.9% -3% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

1.7%

2.6%

-4.5%

SENSEX

0.9%

2.2%

-7.5%


You may also like the below Video Courses